» Articles » PMID: 10090444

Ambulatory Blood Pressure Monitoring in Glaucoma Patients. The Nocturnal Systolic Dip and Its Relationship with Disease Progression

Overview
Journal Int Ophthalmol
Specialty Ophthalmology
Date 1999 Mar 25
PMID 10090444
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study was designed to uncover a new sensitive and specific factor for predicting the progression of glaucoma.

Methods: The 24-hour ambulatory blood pressure and diurnal curve of intra-ocular pressure were recorded in seventy patients: 51 primary open angle glaucoma (POAG) and 19 normal tension glaucoma (NTG). The mean systolic, diastolic and average arterial blood pressure were calculated, along with the nocturnal dip of systolic pressure and diastolic blood pressure. Two-year disease progression was assessed for all patients by means of retrospective analysis of visual fields defects on repeated perimetries.

Results: Abnormal (absence or increased) nocturnal dip of systolic blood pressure was found to be correlated with disease progression in POAG and NTG patients with a sensitivity of 86% and a specificity of 85%, whereas no significant correlation was found for the other risks factors envisaged. Furthermore, a significant relationship between stable visual field defects and the use of diuretics/laser procedure was evidenced.

Conclusion: The nocturnal dip of systolic blood pressure should be considered as a predictive factor of disease progression in NTG and POAG. Further prospective studies are needed to ascertain whether dip normalization could help slow down the visual field loss in these patients.

Citing Articles

Relationship between nocturnal blood pressure dip and β-parapapillary atrophy zone choroidal vessel density in normal-tension glaucoma patients.

Park J, Song W, Baek M, Yoon J, Lee A, Kim K PLoS One. 2025; 20(1):e0317468.

PMID: 39813182 PMC: 11734900. DOI: 10.1371/journal.pone.0317468.


Homocysteine and Glaucoma.

Washington J, Ritch R, Liu Y Int J Mol Sci. 2023; 24(13).

PMID: 37445966 PMC: 10341544. DOI: 10.3390/ijms241310790.


Assessing Usability of Smartwatch Digital Health Devices for Home Blood Pressure Monitoring among Glaucoma Patients.

Bhanvadia S, Brar M, Delavar A, Tavakoli K, Radha Saseendrakumar B, Weinreb R Informatics (MDPI). 2023; 9(4).

PMID: 36873830 PMC: 9980658. DOI: 10.3390/informatics9040079.


Open-Angle Glaucomatous Optic Neuropathy Is Related to Dips Rather Than Increases in the Mean Arterial Pressure Over 24-H.

Melgarejo J, van Eijgen J, Maestre G, Al-Aswad L, Thijs L, Mena L Am J Hypertens. 2022; 35(8):703-714.

PMID: 35218651 PMC: 9340631. DOI: 10.1093/ajh/hpac028.


Assessment of parasympathetic cardiovascular activity in primary open-angle glaucoma.

Awe O, Ogundare O, Adegbehingbe B Int Ophthalmol. 2021; 42(4):1111-1119.

PMID: 34739627 DOI: 10.1007/s10792-021-02097-1.


References
1.
Floras J . Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia. Lancet. 1988; 2(8618):994-6. DOI: 10.1016/s0140-6736(88)90745-3. View

2.
Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T . Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens. 1992; 10(8):875-8. View

3.
Farnett L, Mulrow C, Linn W, Lucey C, Tuley M . The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?. JAMA. 1991; 265(4):489-95. View

4.
Berglund G . Goals of antihypertensive therapy. Is there a point beyond which pressure reduction is dangerous?. Am J Hypertens. 1989; 2(7):586-93. DOI: 10.1093/ajh/2.7.586. View

5.
Munakata M, Imai Y, Abe K, Sasaki S, Minami N, Sekino H . Involvement of the hypothalamo-pituitary-adrenal axis in the control of circadian blood pressure rhythm. J Hypertens Suppl. 1988; 6(4):S44-6. View